choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Rapamycin

Rapamycin Newsletter
  • New England Journal of Medicine Publishes: Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer 05 Feb 2025 22:00 GMT

    treatment options,” said Alison Schram M.D., an attending medical … a private, fully-integrated biotechnology company with a focus in … -AKT-mammalian target of rapamycin pathway. In addition, … About the eNRGy Trial The eNRGy trial (Clinicaltrials.gov NCT02912949 …

  • „New England Journal of Medicine“ veröffentlicht: Wirksamkeit von Zenocutuzumab bei NRG1-fusionspositivem Krebs 05 Feb 2025 22:00 GMT

    … „New England Journal of Medicine“ veröffentlicht: Wirksamkeit von … einem privaten, voll integrierten Biotechnologieunternehmen mit Schwerpunkt auf Hämatologie … AKT-mammalian Target of Rapamycin-Signalweg. Darüber hinaus … for second-line treatment of stage IV …

  • 'Biohacker' Bryan Johnson ditches anti-aging drug rapamycin after it accelerates aging 03 Feb 2025 13:38 GMT

    … use of rapamycin, a controversial anti-ageing drug, after … rapamycin from his regimen, he continues to explore other longevity interventions, stating … has sparked debate among medical professionals, with some … safety of longevity treatments—and whether the …

  • Medical Breakthroughs on Living Longer! 01 Feb 2025 08:45 GMT

    … surgeries, followed by personalized vaccines after surgery, will help … tear, doctors may be able to administer treatments to give … medications, such as the diabetes drug metformin, the immuno¬suppressant rapamycintrials in hopes that, if they work, the FDA

  • Nutritional Diseases and Immunosuppressive Therapy in Patients With kTx 03 Feb 2025 19:11 GMT

    … (kTx) is the most effective treatment for end-stage renal disease … Tac metabolizers. Mammalian target of rapamycin (mTOR) inhibitors was linked to … high-quality, prospective randomized controlled trials.  Source: bmcnephrol.biomedcentral.com…

  • Researchers Astonished by Resilience of Innovative Surgery-Alternating Technique 30 Jan 2025 16:41 GMT

    … merely a transient treatment solution. Rapamycin, the drug used in this … trials designed to assess not only the performance of the treatment … techniqueslong-term treatment efficacynanoparticle applications in medicinenanotechnology drug delivery systempatient …

  • How To Protect Your Brain From Aging: Tips For Brain Health? 05 Feb 2025 07:02 GMT

    … network. • Select pharmacological anti-aging treatments have shown to increase life … the compounds studied. To date rapamycin and 17 α estradiol appear to …

  • A Case Against Longevity Optimization 05 Feb 2025 06:26 GMT

    … experimented with blood transfusions and rapamycin (a drug that may increase lifespan … ). He uses light and oxygen treatments, hyperbaric chambers, supplements, and other … million per year on youthfulness treatments.[3] To be clear, Johnson …

  • Dr. Arlan Richardson, Promises in Modulating the Aging Process 03 Feb 2025 15:09 GMT

    … Moving forward, advancing human trials and reliable anti-aging … in 2009 that rapamycin—a drug used in organ … anti-inflammatory treatments. Are these effective? Richardson: Medications like Ozempic … now spread misinformation about vaccines, but that’s another …

  • Rapamune side effects: What you should know 31 Jan 2025 13:37 GMT

    … occurred in clinical trials, see the prescribing … They may recommend treatment to help reduce … drug classes. Rapamune belongs to a drug class called mammalian target of rapamycindoctor or another healthcare professional before taking any medication. The drug

Satisfied with the content?

Continue to create your account.